ERBB2 and cancer: There were no differences between the two groups in cancer stage, weight of excised breast mass, chemotherapy or radiotherapy status, axillary lymph node status, ER status, PR status, NG, HG, and HER2 amplification after propensity score matching (Table 1, Additional file 2: Table S1).